ArticleF1000Research2021

Fluoxetine pharmacokinetics and tissue distribution quantitatively supports a therapeutic role in COVID-19 at a minimum dose of 20 mg per day.

Andy R EugenePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.